Company Filing History:
Years Active: 2001-2008
Title: The Innovative Contributions of Heidi Tissenbaum
Introduction
Heidi Tissenbaum is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of therapeutic and diagnostic tools, particularly in relation to impaired glucose tolerance conditions. With a total of 3 patents, her work has the potential to impact the medical community significantly.
Latest Patents
One of her latest patents focuses on therapeutic and diagnostic tools for impaired glucose tolerance conditions. This patent discloses novel genes and methods for screening therapeutics useful for treating these conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. Another notable patent involves AGE-1 polypeptides and related molecules and methods. This patent discloses substantially pure AGE-1 polypeptides and purified DNAs, vectors, and cells encoding those polypeptides. It also outlines methods for determining longevity and isolating antagonists using the AGE-1 sequence.
Career Highlights
Heidi Tissenbaum is affiliated with The General Hospital Corporation, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving health outcomes through scientific discovery.
Collaborations
Throughout her career, Tissenbaum has collaborated with notable colleagues, including Gary B Ruvkun and Jason Morris. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Heidi Tissenbaum's innovative work in the field of therapeutic and diagnostic tools showcases her dedication to addressing critical health issues. Her patents and collaborations reflect her significant contributions to science and medicine.